Production (Stage)
Aura Biosciences, Inc.
AURA
$5.89
-$0.05-0.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.00% | -11.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.42% | 19.69% | |||
| Operating Income | -4.42% | -19.69% | |||
| Income Before Tax | -6.41% | -22.91% | |||
| Income Tax Expenses | -25.00% | -44.19% | |||
| Earnings from Continuing Operations | -6.38% | -22.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.38% | -22.77% | |||
| EBIT | -4.42% | -19.69% | |||
| EBITDA | -4.46% | -20.06% | |||
| EPS Basic | -5.99% | -22.09% | |||
| Normalized Basic EPS | -6.01% | -22.21% | |||
| EPS Diluted | -5.99% | -22.09% | |||
| Normalized Diluted EPS | -6.01% | -22.21% | |||
| Average Basic Shares Outstanding | 0.38% | 0.55% | |||
| Average Diluted Shares Outstanding | 0.38% | 0.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||